Clinigen Group Plc: Half Year Revenues Up 17% To £72.6m, Underlying EBITDA Up 8% To £13.5m
Clinigen Group plc (AIM: CLIN, Clinigen or the Group), the global specialty pharmaceuticals and pharmaceutical services business, has today published its half year results for the six months ended 31 December 2014.
Financial highlights
•Group revenue up 17% to £72.6m (H1FY14: £61.8m); on a constant exchange rate basis up 21%
Help employers find you! Check out all the jobs and post your resume.
Financial highlights
•Group revenue up 17% to £72.6m (H1FY14: £61.8m); on a constant exchange rate basis up 21%
Help employers find you! Check out all the jobs and post your resume.